Thursday, January 7, 2021

Ambrx Names CFO, COO

San Diego-based biopharmaceuticals developer Ambrx has named a new Chief Financial Officer and Chief Operating Officer, the company announced this morning. According to Ambryx, it has appointed Gary Young as CFO and COO, following a recent $200M funding round. Young was previously CFO and COO of Erasca, and also served at Guardant Health and Annexon Biosciences, among other companies.